Update of clinical trials from the American College of Cardiology 2003. EPHESUS, SPORTIF-III, ASCOT, COMPANION, UK-PACE and T-wave alternans.
- 9 June 2003
- journal article
- clinical trial
- Published by Wiley in European Journal of Heart Failure
- Vol. 5 (3), 391-398
- https://doi.org/10.1016/s1388-9842(03)00057-6
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Eplerenone, a Selective Aldosterone Blocker, in Patients with Left Ventricular Dysfunction after Myocardial InfarctionNew England Journal of Medicine, 2003
- Major Outcomes in Moderately Hypercholesterolemic, Hypertensive Patients Randomized to Pravastatin vs Usual Care: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT-LLT)JAMA, 2002
- Statins and chronic heart failure: do we need a large-scale outcome trial?Journal of the American College of Cardiology, 2002
- Prophylactic Implantation of a Defibrillator in Patients with Myocardial Infarction and Reduced Ejection FractionNew England Journal of Medicine, 2002
- Is aspirin ″the weakest link” in cardiovascular prophylaxis? The surprising lack of evidence supporting the use of aspirin for cardiovascular diseaseProgress in Cardiovascular Diseases, 2002
- Systematic review of the management of atrial fibrillation in patients with heart failureEuropean Heart Journal, 2000
- The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart FailureNew England Journal of Medicine, 1999
- Quality of Life and Clinical Outcomes in Elderly Patients Treated with Ventricular Pacing as Compared with Dual-Chamber PacingNew England Journal of Medicine, 1998
- Should all patients with atrial fibrillation receive warfarin? Evidence from randomized clinical trialsEuropean Heart Journal, 1996
- Effect of Enalapril on Mortality and the Development of Heart Failure in Asymptomatic Patients with Reduced Left Ventricular Ejection FractionsNew England Journal of Medicine, 1992